| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 15,000 | 06 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | 06 Dec 2023 | 1 | $0 | 4 | Director | 08 Dec 2023, 16:06 |
| CRVS | Corvus Pharmaceuticals, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:57 |
| CRVS | Corvus Pharmaceuticals, Inc. | 11 Aug 2022 | 1 | $0 | 4 | Director | 15 Aug 2022, 18:44 |
| CRVS | Corvus Pharmaceuticals, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 17:26 |
| CRVS | Corvus Pharmaceuticals, Inc. | 09 Sep 2021 | 1 | $0 | 4 | Director | 13 Sep 2021, 16:55 |
| CRVS | Corvus Pharmaceuticals, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:19 |